Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Illinois Tech Journal.
Press releases published on July 10, 2025
Conexis VMS Launches “Nexi AI" Functionality, Continuing to Revolutionize Contingent Workforce Management
EIN Presswire
·
July 10, 2025
Conexis debuts Nexi AI, an AI agent designed to streamline contingent workforce management and enhance VMS client support PARK RIDGE, IL, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- Conexis VMS, a leader in Vendor Management Software, is excited …
J Blanton Plumbing Stands Ready to Help Chicago Flood Victims After Torrential Rains
EIN Presswire
·
July 10, 2025
Following reports of severe flooding from CBS News, local plumbing experts urge residents to protect homes and share strategies to mitigate water damage. NORTHBROOK, IL, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- As torrential rains flood homes …
BAY Miner Cloud Mining App Now Live: Earn Cryptocurrency Daily with No Technical Skills Needed
GlobeNewswire
·
July 10, 2025
Jersey City, NJ, July 10, 2025 (GLOBE NEWSWIRE) -- BAY Miner has officially launched its revolutionary cloud mining app, designed for beginners and crypto enthusiasts alike. With this all-in-one platform, users can now earn cryptocurrency passively—without …
WinnerMining builds a green and reliable cloud mining platform to enable users to steadily participate in the growth of digital assets
GlobeNewswire
·
July 10, 2025
New York, NY, July 10, 2025 (GLOBE NEWSWIRE) -- With the rapid development of cryptocurrencies in the past decade, the global financial landscape is undergoing an unprecedented transformation. In this wave, WinnerMining, an innovative smart cloud mining …
NKGen Biotech Administers First Dose of Troculeucel to Alzheimer’s Patient Who Continued to Decline Cognitively While on Prior Amyloid-Targeting Therapy
GlobeNewswire
·
July 10, 2025
SANTA ANA, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer …
Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 10, 2025
SAN DIEGO, July 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of …
Serina Therapeutics Makes Grant to New Employee Under Inducement Plan
GlobeNewswire
·
July 10, 2025
HUNTSVILLE, AL, July 10, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its lead IND candidate SER-252 for advanced Parkinson's disease, enabled by its proprietary POZ …
Rapid7 to Report Second Quarter 2025 Financial Results on August 7
GlobeNewswire
·
July 10, 2025
BOSTON, July 10, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in threat detection and exposure management, today announced that the company will release its second quarter 2025 financial results on Thursday, August 7, 2025, after the …
Varonis Announces Date of Second Quarter 2025 Financial Results
GlobeNewswire
·
July 10, 2025
MIAMI, July 10, 2025 (GLOBE NEWSWIRE) -- Varonis Systems, Inc. (Nasdaq: VRNS), the leader in data security, announced that it will report its second quarter 2025 financial results following the close of the U.S. financial markets Tuesday, July 29, 2025. In …
Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire
·
July 10, 2025
Nasdaq compliance follows positive upward trend in Company’s Stock Price Jupiter, Florida, July 10, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL …
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
GlobeNewswire
·
July 10, 2025
SOUTH SAN FRANCISCO, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with renal, metabolic and cardiovascular diseases, …
Caro Holdings Introduces Full-Cycle AI Automation Framework to Solve Execution Gaps for Small Businesses
GlobeNewswire
·
July 10, 2025
SHEFFIELD, United Kingdom, July 10, 2025 (GLOBE NEWSWIRE) -- Caro Holdings Inc. (OTC:CAHO), through its subsidiary, announced the launch of a full-cycle AI automation framework to help small and mid-sized businesses implement systems that deliver …
Iovance Biotherapeutics Appoints Marc R. Theoret, M.D. as Senior Vice President, Regulatory Strategy
GlobeNewswire
·
July 10, 2025
SAN CARLOS, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for …
Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
July 10, 2025
WALTHAM, Mass. and BOULDER, Colo., July 10, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the closing of its previously …
MKS Named by Time as One of America’s Best Mid-Sized Companies
GlobeNewswire
·
July 10, 2025
ANDOVER, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ: MKSI), (“MKS”), a global provider of enabling technologies that transform our world, was recognized today as one of America’s Best Mid-Sized Companies for 2025 by Time and Statista, Inc. “ …
Vor Bio Appoints Veteran Biotech Executive Sandy Mahatme as Chief Financial Officer and Chief Business Officer
GlobeNewswire
·
July 10, 2025
Mr. Mahatme brings decades of experience in strategic finance, capital formation, and operational leadership to support company’s transformation and growth in autoimmune disease CAMBRIDGE, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a …
Tevogen’s New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation
GlobeNewswire
·
July 10, 2025
CEO's personal contribution fully funds build-out and first-year operations Doubled HQ footprint centralizes cross-functional teams, including research, regulatory affairs, and the expanding Tevogen.AI initiative WARREN, N.J., July 10, 2025 (GLOBE NEWSWIRE …
CRYPTOSOLO introduces the latest trend in AI-powered cloud mining with a free, one-stop solution for passive crypto income. Mine Bitcoin (BTC) and Dogecoin (DOGE) with zero hardware, no upfront cost, and automated daily payouts. Ideal for b
GlobeNewswire
·
July 10, 2025
London, UK, July 10, 2025 (GLOBE NEWSWIRE) -- In 2025, the cloud mining industry has ushered in a new revolution. As an industry-leading cloud mining platform, CRYPTOSOLO has become the first choice for many cryptocurrency investors with its "free one-stop …
Slipstream Co-Authors First Comprehensive Cost Study on Hereditary Hemorrhagic Telangiectasia in the American Journal of Hematology
GlobeNewswire
·
July 10, 2025
BLUE BELL, Pa., July 10, 2025 (GLOBE NEWSWIRE) -- Slipstream, a trusted technology partner serving the Pharmaceutical and Biopharmaceutical industry, is proud to announce its co-authorship of a groundbreaking study on Hereditary Hemorrhagic Telangiectasia …
Biologic Competition, Payer Pressures, and Gene Therapy Momentum Define a Pivotal Moment in nAMD and DME Management, According to Spherix Global Insights
GlobeNewswire
·
July 10, 2025
Exton, Pennsylvania, July 10, 2025 (GLOBE NEWSWIRE) -- Recently released research from Spherix Global Insights provides a timely look at the increasingly competitive and complex treatment landscape for neovascular age-related macular degeneration (nAMD) …